ZPCK
Product Specifications
UNSPSC Description
ZPCK is an oral active proagent of gemcitabine that was designed for improved oral bioavailability[1].
Target Antigen
Apoptosis; Autophagy; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Apoptosis;Autophagy;Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zpck.html
Purity
99.0
Solubility
DMSO : 33 mg/mL (ultrasonic;warming)
Smiles
O=C(OCC1=CC=CC=C1)N[C@@H](CC2=CC=CC=C2)C(CCl)=O
Molecular Weight
331.79
References & Citations
[1]Zhao C, et al. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats. Cancer Chemother Pharmacol. 2013 Jun;71(6):1541-50.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100709/ZPCK-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100709/ZPCK-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
26049-94-5
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal Cyclin M3 Antibody [Alexa Fluor 405]](https://cdn.genprice.uk/genprice/genprice4.png)
